Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expression.
Andrlová H, Mastroianni J, Madl J, Kern JS, Melchinger W, Dierbach H, Wernet F, Follo M, Technau-Hafsi K, Has C, Rao Mittapalli V, Idzko M, Herr R, Brummer T, Ungefroren H, Busch H, Boerries M, Narr A, Ihorst G, Vennin C, Schmitt-Graeff A, Minguet S, Timpson P, Duyster J, Meiss F, Römer W, Zeiser R. Andrlová H, et al. Oncotarget. 2017 Jun 27;8(26):42901-42916. doi: 10.18632/oncotarget.17160. Oncotarget. 2017. PMID: 28476030 Free PMC article.
miR-146a Controls Immune Response in the Melanoma Microenvironment.
Mastroianni J, Stickel N, Andrlova H, Hanke K, Melchinger W, Duquesne S, Schmidt D, Falk M, Andrieux G, Pfeifer D, Dierbach H, Schmitt-Graeff A, Meiss F, Boerries M, Zeiser R. Mastroianni J, et al. Among authors: andrlova h. Cancer Res. 2019 Jan 1;79(1):183-195. doi: 10.1158/0008-5472.CAN-18-1397. Epub 2018 Nov 13. Cancer Res. 2019. PMID: 30425059 Free PMC article.
Immunotherapy for malignant melanoma.
Zeiser R, Schnitzler M, Andrlova H, Hellige T, Meiss F. Zeiser R, et al. Among authors: andrlova h. Curr Stem Cell Res Ther. 2012 May;7(3):217-28. doi: 10.2174/157488812799859883. Curr Stem Cell Res Ther. 2012. PMID: 22329580 Review.
Trametinib (GSK1120212).
Zeiser R, Andrlová H, Meiss F. Zeiser R, et al. Among authors: andrlova h. Recent Results Cancer Res. 2018;211:91-100. doi: 10.1007/978-3-319-91442-8_7. Recent Results Cancer Res. 2018. PMID: 30069762 Review.
B-Raf inhibitors induce epithelial differentiation in BRAF-mutant colorectal cancer cells.
Herr R, Köhler M, Andrlová H, Weinberg F, Möller Y, Halbach S, Lutz L, Mastroianni J, Klose M, Bittermann N, Kowar S, Zeiser R, Olayioye MA, Lassmann S, Busch H, Boerries M, Brummer T. Herr R, et al. Among authors: andrlova h. Cancer Res. 2015 Jan 1;75(1):216-29. doi: 10.1158/0008-5472.CAN-13-3686. Epub 2014 Nov 7. Cancer Res. 2015. PMID: 25381152
Cobimetinib (GDC-0973, XL518).
Andrlová H, Zeiser R, Meiss F. Andrlová H, et al. Recent Results Cancer Res. 2018;211:177-186. doi: 10.1007/978-3-319-91442-8_12. Recent Results Cancer Res. 2018. PMID: 30069767 Review.
Vismodegib.
Meiss F, Andrlová H, Zeiser R. Meiss F, et al. Among authors: andrlova h. Recent Results Cancer Res. 2018;211:125-139. doi: 10.1007/978-3-319-91442-8_9. Recent Results Cancer Res. 2018. PMID: 30069764 Review.
Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancer.
Jägle S, Rönsch K, Timme S, Andrlová H, Bertrand M, Jäger M, Proske A, Schrempp M, Yousaf A, Michoel T, Zeiser R, Werner M, Lassmann S, Hecht A. Jägle S, et al. Among authors: andrlova h. Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4886-91. doi: 10.1073/pnas.1314523111. Epub 2014 Mar 18. Proc Natl Acad Sci U S A. 2014. PMID: 24707046 Free PMC article.
BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia.
Yaktapour N, Meiss F, Mastroianni J, Zenz T, Andrlova H, Mathew NR, Claus R, Hutter B, Fröhling S, Brors B, Pfeifer D, Pantic M, Bartsch I, Spehl TS, Meyer PT, Duyster J, Zirlik K, Brummer T, Zeiser R. Yaktapour N, et al. Among authors: andrlova h. J Clin Invest. 2014 Nov;124(11):5074-84. doi: 10.1172/JCI76539. Epub 2014 Oct 20. J Clin Invest. 2014. PMID: 25329694 Free PMC article.
MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT.
Andrlová H, Miltiadous O, Kousa AI, Dai A, DeWolf S, Violante S, Park HY, Janaki-Raman S, Gardner R, El Daker S, Slingerland J, Giardina P, Clurman A, Gomes ALC, Nguyen C, da Silva MB, Armijo GK, Lee N, Zappasodi R, Chaligne R, Masilionis I, Fontana E, Ponce D, Cho C, Bush A, Hill L, Chao N, Sung AD, Giralt S, Vidal EH, Hosszu KK, Devlin SM, Peled JU, Cross JR, Perales MA, Godfrey DI, van den Brink MRM, Markey KA. Andrlová H, et al. Sci Transl Med. 2022 May 25;14(646):eabj2829. doi: 10.1126/scitranslmed.abj2829. Epub 2022 May 25. Sci Transl Med. 2022. PMID: 35613281 Free PMC article.
19 results